• Picard Medical issued $1 million of unsecured convertible notes to three accredited investors on Sept. 30, 2026.
• Notes carry 3% annual interest, mature Sept. 30, 2027, with holders able to accelerate on an event of default.
• Holders can convert outstanding balances into common stock at the higher of $4.00 a share or prior-day close.
• Conversion at the $4.00 floor implies up to 250,000 shares, excluding interest, with matching pre-funded warrants for up to 250,000 shares.
• Company can force conversion upon a $10 million equity financing, subject to NYSE American 19.99% issuance limit without stockholder approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Picard Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-032125), on October 06, 2026, and is solely responsible for the information contained therein.